InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Foster-Cheek Kaye I, Director. Director active across 2 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 10 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €46k. History available since 28 May 2021. The latest transaction was filed on 20 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Foster-Cheek Kaye I
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
2,816 sharesCommon stockSEC:0001439222-26-000103:0
2,120 shares0Common stockSEC:0001439222-25-000057:0
3,388 shares0Common stockSEC:0001439222-24-000091:0
1,285 shares@ US$31.628.1% of flowCommon stockSEC:0001439222-24-000061:0
300 shares@ US$32.211.9% of flowCommon stockSEC:0001439222-24-000058:0
25,000 shares@ US$18.0989.9% of flowCommon stockSEC:0001439222-23-000125:0
4,975 shares0Common stockSEC:0001439222-23-000097:0
2,200 shares0Common stockSEC:0001439222-23-000006:0
1,585 shares0Common stockSEC:0001439222-22-000048:0
1,686 shares0Common stockSEC:0001439222-21-000053:0
10 of 10 declarations
About Foster-Cheek Kaye I
Foster-Cheek Kaye I is Administrateur at AGIOS PHARMACEUTICALS, INC. and Agios Pharmaceuticals, INC. The 10 filings on record cover the period from 2021-06-02 to 2026-06-23 in the sampled recent filings, with sell volume of EUR 46180 and no buy volume; the most frequent transaction nature is Levée d'options.
